| Year |
Citation |
Score |
| 2023 |
Ribeiro CMP, Higgs MG, Muhlebach MS, Wolfgang MC, Borgatti M, Lampronti I, Cabrini G. Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators. International Journal of Molecular Sciences. 24. PMID 36902441 DOI: 10.3390/ijms24055010 |
0.357 |
|
| 2022 |
Lu KY, Wagner NJ, Velez AZ, Ceppe A, Conlon BP, Muhlebach MS. Antibiotic Tolerance and Treatment Outcomes in Cystic Fibrosis Methicillin-Resistant Staphylococcus aureus Infections. Microbiology Spectrum. 11: e0406122. PMID 36519944 DOI: 10.1128/spectrum.04061-22 |
0.376 |
|
| 2022 |
Lo DK, Muhlebach MS, Smyth AR. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 12: CD009650. PMID 36511181 DOI: 10.1002/14651858.CD009650.pub5 |
0.402 |
|
| 2022 |
Stoudemire W, Jiang X, Zhou JJ, Kosorok MR, Saiman L, Muhlebach MS. Predicting risk-adjusted incidence rates of methicillin-resistant Staphylococcus Aureus and Pseudomonas Aeruginosa in cystic fibrosis programs in the United States. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35963814 DOI: 10.1016/j.jcf.2022.08.002 |
0.349 |
|
| 2022 |
Batson B, Zorn B, Radicioni G, Livengood S, Kumagai T, Dang H, Ceppe A, Clapp P, Tunney M, Elborn S, McElvaney G, Muhlebach M, Boucher RC, Tiemeyer M, Wolfgang M, et al. Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promote Disease Persistence. American Journal of Respiratory Cell and Molecular Biology. PMID 35486871 DOI: 10.1165/rcmb.2021-0359OC |
0.371 |
|
| 2022 |
Markovetz MR, Garbarine IC, Morrison CB, Kissner WJ, Seim I, Forest MG, Papanikolas MJ, Freeman R, Ceppe A, Ghio A, Alexis NE, Stick SM, Ehre C, Boucher RC, Esther CR, ... Muhlebach MS, et al. Mucus and mucus flake composition and abundance reflect inflammatory and infection status in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35437233 DOI: 10.1016/j.jcf.2022.04.008 |
0.387 |
|
| 2021 |
Muhlebach MS, Jiang X, Kosorok MR, Klein EY, Saiman L. Longitudinal changes and regional variation of incident infection rates at cystic fibrosis centers, United States 2010-2016. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 34456157 DOI: 10.1016/j.jcf.2021.08.009 |
0.307 |
|
| 2021 |
Gilpin D, Hoffman LR, Ceppe A, Muhlebach MS. Phenotypic characteristics of incident and chronic MRSA isolates in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 34103251 DOI: 10.1016/j.jcf.2021.05.015 |
0.352 |
|
| 2020 |
Hoppe JE, Guimbellot J, Martiniano SL, Toprak D, Davis C, Daines CL, Muhlebach MS, Esther CR, Dellon EP. Highlights From the 2019 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 32573948 DOI: 10.1002/Ppul.24919 |
0.429 |
|
| 2020 |
Bullington W, Hempstead S, Smyth AR, Drevinek P, Saiman L, Waters VJ, Bell SC, VanDevanter DR, Flume PA, Elborn S, Muhlebach MS. Antimicrobial resistance: Concerns of healthcare providers and people with CF. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32563724 DOI: 10.1016/J.Jcf.2020.05.009 |
0.465 |
|
| 2020 |
Cogen JD, Kahl BC, Maples H, McColley SA, Roberts JA, Winthrop KL, Morris AM, Holmes A, Flume PA, VanDevanter DR, Waters V, Muhlebach MS, Elborn JS, Saiman L, Bell SC, et al. Finding the relevance of antimicrobial stewardship for cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32122785 DOI: 10.1016/J.Jcf.2020.02.012 |
0.468 |
|
| 2019 |
Muhlebach MS, Sha W, MacIntosh B, Kelley TJ, Muenzer J. Metabonomics reveals altered metabolites related to inflammation and energy utilization at recovery of cystic fibrosis lung exacerbation. Metabolism Open. 3: 100010. PMID 32812947 DOI: 10.1016/j.metop.2019.100010 |
0.364 |
|
| 2019 |
Sagel SD, Wagner BD, Ziady A, Kelley T, Clancy JP, Narvaez-Rivas M, Pilewski J, Joseloff E, Sha W, Zelnick L, Setchell KDR, Heltshe SL, Muhlebach MS. Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31870630 DOI: 10.1016/J.Jcf.2019.12.007 |
0.423 |
|
| 2019 |
Martiniano SL, Daines CL, Dellon EP, Esther CR, Muhlebach MS, Ong T, Rabinowitz EC, Toprak D, Zemanick ET. Highlights from the 2018 North American cystic fibrosis conference. Pediatric Pulmonology. PMID 31091021 DOI: 10.1002/Ppul.24356 |
0.42 |
|
| 2019 |
Stoudemire W, Jiang X, Zhou JJ, Maykowski P, Kosorok MR, Muhlebach MS, Saiman L. Cystic fibrosis program characteristics associated with adoption of 2013 infection prevention and control recommendations. American Journal of Infection Control. PMID 31036402 DOI: 10.1016/J.Ajic.2019.03.015 |
0.395 |
|
| 2019 |
Esther CR, Muhlebach MS, Ehre C, Hill DB, Wolfgang MC, Kesimer M, Ramsey KA, Markovetz MR, Garbarine IC, Forest MG, Seim I, Zorn B, Morrison CB, Delion MF, Thelin WR, et al. Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis. Science Translational Medicine. 11. PMID 30944166 DOI: 10.1126/Scitranslmed.Aav3488 |
0.518 |
|
| 2019 |
Sherrard LJ, Einarsson GG, Johnston E, O'Neill K, McIlreavey L, McGrath SJ, Gilpin DF, Downey DG, Reid A, McElvaney NG, Boucher RC, Muhlebach MS, Elborn JS, Tunney MM. Assessment of stability and fluctuations of cultured lower airway bacterial communities in people with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30905581 DOI: 10.1016/J.Jcf.2019.02.012 |
0.392 |
|
| 2019 |
Bullington W, Smyth A, Elborn S, Drevinek P, Hempstead S, Muhlebach M. 1078. Expectations and Attitudes Toward Antimicrobial Stewardship Among Cystic Fibrosis Care Providers Open Forum Infectious Diseases. 6: S382-S383. DOI: 10.1093/Ofid/Ofz360.942 |
0.504 |
|
| 2019 |
Sherrard L, Allen D, Barron M, Einarsson G, Johnston E, O'Neill K, McIlreavey L, McGrath S, Gilpin D, Downey D, Reid A, McElvaney N, Boucher R, Muhlebach M, Elborn J, et al. P179 Detection of multi-drug resistant (MDR) Pseudomonas aeruginosa (PA) in people with cystic fibrosis Journal of Cystic Fibrosis. 18: S108. DOI: 10.1016/S1569-1993(19)30473-4 |
0.366 |
|
| 2019 |
Einarsson G, Sherrard L, Zorn B, Hatch J, McGettigan C, Bradbury I, Campbell C, Johnston E, O'Neill K, McIlreavey L, McGrath S, Gilpin D, Murray M, Lavelle G, McElvaney G, ... ... Muhlebach M, et al. P140 Microbial community composition in cystic fibrosis patients during treatment for pulmonary exacerbation Journal of Cystic Fibrosis. 18: S97. DOI: 10.1016/S1569-1993(19)30434-5 |
0.392 |
|
| 2018 |
Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Stuart Elborn J, Tunney MM. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. The Journal of Antimicrobial Chemotherapy. 73: 3218. PMID 30351435 DOI: 10.1093/jac/dky313 |
0.43 |
|
| 2018 |
Akil N, Muhlebach MS. Biology and management of methicillin resistant Staphylococcus aureus in cystic fibrosis. Pediatric Pulmonology. PMID 30073802 DOI: 10.1002/Ppul.24139 |
0.472 |
|
| 2018 |
Lo DK, Muhlebach MS, Smyth AR. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 7: CD009650. PMID 30030966 DOI: 10.1002/14651858.CD009650.pub4 |
0.402 |
|
| 2018 |
Sanders CD, Guimbellot JS, Muhlebach MS, Lin FC, Gilligan P, Esther CR. Tracheostomy in children: Epidemiology and clinical outcomes. Pediatric Pulmonology. PMID 29968973 DOI: 10.1002/Ppul.24071 |
0.345 |
|
| 2018 |
Muhlebach MS, Hatch JE, Einarsson GG, McGrath SJ, Gilipin DF, Lavelle G, Mirkovic B, Murray MA, McNally P, Gotman N, Davis Thomas S, Wolfgang MC, Gilligan PH, McElvaney NG, Elborn JS, et al. Anaerobic bacteria cultured from CF airways correlate to milder disease-a multisite study. The European Respiratory Journal. PMID 29946004 DOI: 10.1183/13993003.00242-2018 |
0.42 |
|
| 2018 |
Kuti JL, Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP. Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations. Diagnostic Microbiology and Infectious Disease. PMID 29661528 DOI: 10.1016/J.Diagmicrobio.2018.01.020 |
0.398 |
|
| 2018 |
Martiniano SL, Toprak D, Ong T, Zemanick ET, Daines CL, Muhlebach MS, Esther CR, Dellon EP. Highlights from the 2017 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 29660839 DOI: 10.1002/Ppul.24000 |
0.447 |
|
| 2018 |
Saiman L, Zhou JJ, Jiang X, Kosorok MR, Muhlebach MS. Surveying Cystic Fibrosis Care Centers to Assess Adoption of Infection Prevention and Control Recommendations. Infection Control and Hospital Epidemiology. 1-5. PMID 29655374 DOI: 10.1017/Ice.2018.72 |
0.428 |
|
| 2018 |
Muhlebach MS, Zorn BT, Esther CR, Hatch JE, Murray CP, Turkovic L, Ranganathan SC, Boucher RC, Stick SM, Wolfgang MC. Initial acquisition and succession of the cystic fibrosis lung microbiome is associated with disease progression in infants and preschool children. Plos Pathogens. 14: e1006798. PMID 29346420 DOI: 10.1371/Journal.Ppat.1006798 |
0.476 |
|
| 2018 |
MCGettigan C, Spence C, Lee A, Sherrard L, Johnston E, Einarsson G, Elborn J, Downey D, Muhlebach M, Boucher R, MCElvaney G, Michelle M, Lavelle G, Tunney M, Gilpin D. P073 Use of qPCR to analyse changes in total bacterial and Pseudomonas aeruginosa load in cystic fibrosis patients when clinically stable and during exacerbations Journal of Cystic Fibrosis. 17: S80. DOI: 10.1016/S1569-1993(18)30370-9 |
0.402 |
|
| 2018 |
Einarsson G, Sherrard L, Johnston E, O'Neill K, McIlreavey L, MCGrath S, Gilpin D, Murray M, Lavelle G, MCElvaney G, Boucher R, Muhlebach M, Elborn J, Tunney M. P070 Longitudinal analysis of the lower airway microbiota in cystic fibrosis patients during clinical stability compared to those experiencing episodes of pulmonary exacerbation Journal of Cystic Fibrosis. 17: S79. DOI: 10.1016/S1569-1993(18)30367-9 |
0.439 |
|
| 2018 |
Einarsson G, Sherrard L, Johnston E, O'neill K, Mcllreavey L, McGrath S, Gilpin D, Murray M, Lavelle G, McElvaney G, Muhlebach M, Elborn J, Tunney M. P055 A cross-sectional analysis of cough swabs from non-expectorating CF patients and healthy control participants Journal of Cystic Fibrosis. 17: S74-S75. DOI: 10.1016/S1569-1993(18)30352-7 |
0.351 |
|
| 2017 |
Muhlebach MS. Methicillin-resistant Staphylococcus aureus in cystic fibrosis: how should it be managed? Current Opinion in Pulmonary Medicine. PMID 28796008 DOI: 10.1097/Mcp.0000000000000422 |
0.495 |
|
| 2017 |
Zemanick ET, Daines CL, Dellon EP, Esther CR, Kinghorn B, Ong T, Muhlebach MS. Highlights from the 2016 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 28696526 DOI: 10.1002/Ppul.23707 |
0.441 |
|
| 2017 |
Gilpin D, Torres-Bustos J, Carson G, Payne J, Hoffman L, O'Leary C, Muhlebach M. 106 Characterisation of MRSA from initial versus chronic infection in CF patients Journal of Cystic Fibrosis. 16: S92. DOI: 10.1016/S1569-1993(17)30470-8 |
0.44 |
|
| 2016 |
Muhlebach MS, Clancy JP, Heltshe SL, Ziady A, Kelley T, Accurso F, Pilewski J, Mayer-Hamblett N, Joseloff E, Sagel SD. Biomarkers for cystic fibrosis drug development. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 15: 714-723. PMID 28215711 DOI: 10.1016/J.Jcf.2016.10.009 |
0.31 |
|
| 2016 |
Muhlebach MS, Beckett V, Popowitch E, Miller MB, Baines A, Mayer-Hamblett N, Zemanick ET, Hoover WC, VanDalfsen JM, Campbell P, Goss CH. Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial. Thorax. PMID 27852955 DOI: 10.1136/Thoraxjnl-2016-208949 |
0.424 |
|
| 2016 |
Esther CR, Turkovic L, Rosenow T, Muhlebach MS, Boucher RC, Ranganathan S, Stick SM. Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis. The European Respiratory Journal. PMID 27836957 DOI: 10.1183/13993003.00524-2016 |
0.389 |
|
| 2016 |
Monogue ML, Pettit RS, Muhlebach M, Cies JJ, Nicolau DP, Kuti JL. Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation. Antimicrobial Agents and Chemotherapy. 60: 6578-6584. PMID 27550351 DOI: 10.1128/Aac.01566-16 |
0.446 |
|
| 2016 |
Zemanick ET, Ong T, Daines CL, Dellon EP, Muhlebach MS, Esther CR. Highlights from the 2015 North American Cystic Fibrosis Conference. Pediatric Pulmonology. PMID 27074261 DOI: 10.1002/Ppul.23441 |
0.328 |
|
| 2016 |
Pattison S, Oram L, Johnston E, Lavelle G, Murray M, McElvaney N, Muhlebach M, Boucher R, Crockard M, Tunney M, Elborn J. 115 Prevalence of respiratory viruses in CF patients when clinically stable and during pulmonary exacerbation Journal of Cystic Fibrosis. 15: S80. DOI: 10.1016/S1569-1993(16)30353-8 |
0.453 |
|
| 2016 |
Muhlebach M, O'Leary C, Sha W. 88 Metabolomic signatures of cystic fibrosis exacerbations Journal of Cystic Fibrosis. 15: S73. DOI: 10.1016/S1569-1993(16)30327-7 |
0.377 |
|
| 2015 |
Sherrard LJ, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Elborn JS, Tunney MM. Production of extended-spectrum β-lactamases and the potential indirect pathogenic role of Prevotella isolates from the cystic fibrosis respiratory microbiota. International Journal of Antimicrobial Agents. PMID 26774156 DOI: 10.1016/J.Ijantimicag.2015.12.004 |
0.451 |
|
| 2015 |
Muhlebach MS, Sha W. Lessons learned from metabolomics in cystic fibrosis. Molecular and Cellular Pediatrics. 2: 9. PMID 26542299 DOI: 10.1186/S40348-015-0020-8 |
0.444 |
|
| 2015 |
Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP, Kuti JL. Population pharmacokinetics of meropenem administered as a prolonged infusion in children with cystic fibrosis. The Journal of Antimicrobial Chemotherapy. PMID 26416780 DOI: 10.1093/Jac/Dkv289 |
0.402 |
|
| 2015 |
Heltshe SL, Saiman L, Popowitch EB, Miller MB, Kloster M, Thompson V, Ferkol TW, Hoover WC, Schechter MS, Muhlebach MS. Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis. Journal of the Pediatric Infectious Diseases Society. 4: 225-31. PMID 26336603 DOI: 10.1093/Jpids/Piu048 |
0.463 |
|
| 2015 |
Mirković B, Murray MA, Lavelle GM, Molloy K, Azim AA, Gunaratnam C, Healy F, Slattery D, McNally P, Hatch J, Wolfgang M, Tunney MM, Muhlebach MS, Devery R, Greene CM, et al. Short-chain Fatty Acids Cause an IL-8 Response in Cystic Fibrosis Airways via Increased GPR41. American Journal of Respiratory and Critical Care Medicine. PMID 26266556 DOI: 10.1164/Rccm.201505-0943Oc |
0.321 |
|
| 2015 |
Kuti JL, Pettit RS, Neu N, Cies JJ, Lapin C, Muhlebach MS, Novak KJ, Nguyen ST, Saiman L, Nicolau DP. Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis. Diagnostic Microbiology and Infectious Disease. PMID 26003469 DOI: 10.1016/J.Diagmicrobio.2015.04.012 |
0.385 |
|
| 2015 |
Lo DK, Hurley MN, Muhlebach MS, Smyth AR. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 2: CD009650. PMID 25927091 DOI: 10.1002/14651858.Cd009650.Pub3 |
0.496 |
|
| 2015 |
Muhlebach MS, Heltshe SL, Popowitch EB, Miller MB, Thompson V, Kloster M, Ferkol T, Hoover WC, Schechter MS, Saiman L. Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis. Annals of the American Thoracic Society. 12: 864-71. PMID 25745825 DOI: 10.1513/Annalsats.201412-596Oc |
0.442 |
|
| 2015 |
Lo DKh, Hurley MN, Muhlebach MS, Smyth AR. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 2: CD009650. PMID 25710333 DOI: 10.1002/14651858.CD009650.pub3 |
0.418 |
|
| 2015 |
Sherrard L, Matier T, Nixon K, McGrath S, McIlreavey L, Hatch J, Wolfgang M, Muhlebach M, Gilpin D, Elborn J, Tunney M. 93 Production of virulence factors by Prevotella isolates belonging to the cystic fibrosis (CF) respiratory microbiota Journal of Cystic Fibrosis. 14: S81. DOI: 10.1016/S1569-1993(15)30270-8 |
0.451 |
|
| 2015 |
Gilpin D, Murdock S, Hoffman L, Vallières E, McGrath S, Tunney M, Elborn J, Muhlebach M. WS02.7 Initial and chronic MRSA infection in cystic fibrosis Journal of Cystic Fibrosis. 14: S4. DOI: 10.1016/S1569-1993(15)30013-8 |
0.485 |
|
| 2015 |
Goss C, Thompson V, Popowitch E, Howe D, Baines A, Mayer-Hamblett N, Jill V, Muhlebach M. WS02.1 Efficacy of a protocol for eradication of newly acquired MRSA: Results of the STAR-too trial Journal of Cystic Fibrosis. 14: S3. DOI: 10.1016/S1569-1993(15)30007-2 |
0.326 |
|
| 2014 |
Sherrard LJ, Schaible B, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Wolfgang MC, Muhlebach MS, Gilpin DF, Schneiders T, Elborn JS, Tunney MM. Mechanisms of reduced susceptibility and genotypic prediction of antibiotic resistance in Prevotella isolated from cystic fibrosis (CF) and non-CF patients. The Journal of Antimicrobial Chemotherapy. 69: 2690-8. PMID 24917582 DOI: 10.1093/Jac/Dku192 |
0.513 |
|
| 2014 |
Joseloff E, Sha W, Bell SC, Wetmore DR, Lawton KA, Milburn MV, Ryals JA, Guo L, Muhlebach MS. Serum metabolomics indicate altered cellular energy metabolism in children with cystic fibrosis. Pediatric Pulmonology. 49: 463-72. PMID 23847148 DOI: 10.1002/Ppul.22859 |
0.385 |
|
| 2014 |
Champion EA, Miller MB, Popowitch EB, Hobbs MM, Saiman L, Muhlebach MS. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. Pediatric Pulmonology. 49: 230-7. PMID 23765686 DOI: 10.1002/Ppul.22815 |
0.49 |
|
| 2014 |
Sherrard L, Matier T, Gilpin D, Muhlebach M, Elborn J, Schneiders T, Tunney M. 71 Extended-spectrum β-lactamase (ESβL) production: a mechanism of resistance to ceftazidime in Prevotella species isolated from patients with CF Journal of Cystic Fibrosis. 13: S64. DOI: 10.1016/S1569-1993(14)60207-1 |
0.394 |
|
| 2014 |
Tunney M, Hatch J, Lavelle G, McGrath S, Johnston E, Murray M, Boucher R, Elborn J, McElvaney G, Randell S, Wolfgang M, Muhlebach M. WS21.6 Comparison of the CF airway microbiome obtained by bronchoscopy vs. sputum Journal of Cystic Fibrosis. 13: S42. DOI: 10.1016/S1569-1993(14)60131-4 |
0.35 |
|
| 2014 |
Hatch J, Kim J, McGrath S, McIlreavey L, Gilpin D, Lavelle G, Murray M, Boucher R, Elborn J, McElvaney N, Muhlebach M, Tunney M, Wolfgang M, Randell S. WS2.9 Inflammatory potential and antimicrobial susceptibility of bacteria in the cultivatable CF lung microbiome Journal of Cystic Fibrosis. 13: S5. DOI: 10.1016/S1569-1993(14)60018-7 |
0.324 |
|
| 2014 |
Sherrard L, Matier T, Gilpin D, Muhlebach MS, Elborn J, Tunney MM. Characterization of extended-spectrum β-Lactamase production by prevotella species from cystic fibrosis patients and detection of tem-type genes Pediatric Pulmonology. 49. DOI: 10.1002/Ppul.23108 |
0.333 |
|
| 2013 |
Sherrard LJ, Graham KA, McGrath SJ, McIlreavey L, Hatch J, Muhlebach MS, Wolfgang MC, Gilpin DF, Elborn JS, Schneiders T, Tunney MM. Antibiotic resistance in Prevotella species isolated from patients with cystic fibrosis. The Journal of Antimicrobial Chemotherapy. 68: 2369-74. PMID 23696621 DOI: 10.1093/Jac/Dkt191 |
0.523 |
|
| 2013 |
Lo DK, Hurley MN, Muhlebach MS, Smyth AR. Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 2: CD009650. PMID 23450608 DOI: 10.1002/14651858.CD009650.pub2 |
0.417 |
|
| 2013 |
Ghio AJ, Roggli VL, Soukup JM, Richards JH, Randell SH, Muhlebach MS. Iron accumulates in the lavage and explanted lungs of cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 390-8. PMID 23176785 DOI: 10.1016/J.Jcf.2012.10.010 |
0.368 |
|
| 2013 |
Matier T, Tunney M, Valvano M, Muhlebach M, Hatch J, Wolfgang M, Elborn J. 118 Characterisation of lipopolysaccharide from Prevotella spp. isolated from CF patients Journal of Cystic Fibrosis. 12: S78. DOI: 10.1016/S1569-1993(13)60260-X |
0.476 |
|
| 2013 |
Sherrard L, Graham K, McGrath S, McIlreavey L, Hatch J, Muhlebach M, Gilpin D, Elborn J, Schneiders T, Tunney M. 84 Azithromycin resistance in Prevotella species isolated from CF patients Journal of Cystic Fibrosis. 12: S70. DOI: 10.1016/S1569-1993(13)60226-X |
0.486 |
|
| 2013 |
Schaible B, Sherrard L, Gilpin D, Elborn JS, Muhlebach MS, Tunney M. Investigation of RND Efflux Pumps in Clinical Prevotella Species isolated from CF Patients: Pediatric Pulmonology Pediatric Pulmonology. 48. DOI: 10.1002/Ppul.22898 |
0.417 |
|
| 2012 |
Hatch J, Sherrard L, Graham K, Muhlebach MS, Gilpin D, Elborn S, Schneiders T, Tunney M. PREVOTELLA SPECIES ISOLATED FROM CF PATIENTS: ANTIBIOTIC SUSCEPTIBILITY AND PRESENCE OF ANTIBIOTIC RESISTANCE GENES: Pediatric Pulmonology Pediatric Pulmonology. 47. DOI: 10.1002/Ppul.22682 |
0.44 |
|
| 2011 |
Goss CH, Muhlebach MS. Review: Staphylococcus aureus and MRSA in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 298-306. PMID 21719362 DOI: 10.1016/J.Jcf.2011.06.002 |
0.456 |
|
| 2011 |
Lu KD, Engmann C, Moya F, Muhlebach M. Cystic fibrosis in premature infants. Journal of Perinatology : Official Journal of the California Perinatal Association. 31: 504-6. PMID 21712830 DOI: 10.1038/Jp.2010.198 |
0.403 |
|
| 2011 |
Keel RA, Schaeftlein A, Kloft C, Pope JS, Knauft RF, Muhlebach M, Nicolau DP, Kuti JL. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis. Antimicrobial Agents and Chemotherapy. 55: 3393-8. PMID 21518837 DOI: 10.1128/Aac.01797-10 |
0.361 |
|
| 2011 |
Muhlebach MS, Wooten W, Muenzer J. Respiratory manifestations in mucopolysaccharidoses. Paediatric Respiratory Reviews. 12: 133-8. PMID 21458742 DOI: 10.1016/J.Prrv.2010.10.005 |
0.34 |
|
| 2011 |
Muhlebach MS, Miller M, LaVange LM, Mayhew G, Goodrich JS, Miller MB. Treatment intensity and characteristics of MRSA infection in CF. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 10: 201-6. PMID 21420912 DOI: 10.1016/J.Jcf.2011.02.004 |
0.374 |
|
| 2011 |
Harris WT, Muhlebach MS, Oster RA, Knowles MR, Clancy JP, Noah TL. Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatric Pulmonology. 46: 688-95. PMID 21337732 DOI: 10.1002/Ppul.21430 |
0.435 |
|
| 2011 |
Tunney MM, Klem ER, Fodor AA, Gilpin DF, Moriarty TF, McGrath SJ, Muhlebach MS, Boucher RC, Cardwell C, Doering G, Elborn JS, Wolfgang MC. Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis. Thorax. 66: 579-84. PMID 21270069 DOI: 10.1136/Thx.2010.137281 |
0.482 |
|
| 2011 |
Gilpin D, McGrath S, McCaughan J, Reid A, Rendall J, Elborn J, Muhlebach M, Tunney M. 161* Expression of virulence factors in methicillin resistant Staphylococcus aureus (MRSA) isolates from cystic fibrosis sputum Journal of Cystic Fibrosis. 10: S41. DOI: 10.1016/S1569-1993(11)60177-X |
0.367 |
|
| 2011 |
Muhlebach M, Champion E, Popowitch E, Miller M, Saiman L. 133* Characteristics and susceptibilities of methicillin resistant Staphylococcus aureus in paediatric cystic fibrosis patients in the USA Journal of Cystic Fibrosis. 10: S34. DOI: 10.1016/S1569-1993(11)60150-1 |
0.464 |
|
| 2010 |
Gilpin D, McGrath S, McCaughan J, Muhlebach M, Skov R, Reid A, Elborn J, Tunney M. Comparison and characterization of MRSA isolates from paediatric CF patients Journal of Cystic Fibrosis. 9: S32. DOI: 10.1016/S1569-1993(10)60125-7 |
0.487 |
|
| 2009 |
Harris WT, Muhlebach MS, Oster RA, Knowles MR, Noah TL. Transforming growth factor-beta(1) in bronchoalveolar lavage fluid from children with cystic fibrosis. Pediatric Pulmonology. 44: 1057-64. PMID 19830844 DOI: 10.1002/Ppul.21079 |
0.413 |
|
| 2009 |
Tunney M, Klem E, Gilpin D, McGrath S, Muhlebach M, Boucher R, Elborn J, Wolfgang M. Detection of anaerobic bacteria in bronchoalveolar lavage fluid from paediatric CF patients Journal of Cystic Fibrosis. 8: S45. DOI: 10.1016/S1569-1993(09)60180-6 |
0.378 |
|
| 2009 |
Gilpin D, McCaughan J, Muhlebach M, Macfarlane M, Reid A, Elborn J, Ziebuhr W, Tunney M. Comparison of MRSA isolated from patients in two paediatric CF centres Journal of Cystic Fibrosis. 8: S42. DOI: 10.1016/S1569-1993(09)60167-3 |
0.425 |
|
| 2008 |
Tunney MM, Field TR, Moriarty TF, Patrick S, Doering G, Muhlebach MS, Wolfgang MC, Boucher R, Gilpin DF, McDowell A, Elborn JS. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 177: 995-1001. PMID 18263800 DOI: 10.1164/Rccm.200708-1151Oc |
0.485 |
|
| 2008 |
Lorenz E, Muhlebach MS, Tessier PA, Alexis NE, Duncan Hite R, Seeds MC, Peden DB, Meredith W. Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases. Respiratory Medicine. 102: 567-73. PMID 18164192 DOI: 10.1016/J.Rmed.2007.11.011 |
0.416 |
|
| 2006 |
Muhlebach MS, MacDonald SL, Button B, Hubbard JJ, Turner ML, Boucher RC, Kilpatrick DC. Association between mannan-binding lectin and impaired lung function in cystic fibrosis may be age-dependent. Clinical and Experimental Immunology. 145: 302-7. PMID 16879250 DOI: 10.1111/J.1365-2249.2006.03151.X |
0.4 |
|
| 2006 |
Muhlebach MS, Miller MB, Moore C, Wedd JP, Drake AF, Leigh MW. Are lower airway or throat cultures predictive of sinus bacteriology in cystic fibrosis? Pediatric Pulmonology. 41: 445-51. PMID 16547960 DOI: 10.1002/Ppul.20396 |
0.399 |
|
| 2006 |
Alexis NE, Muhlebach MS, Peden DB, Noah TL. Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 5: 17-25. PMID 16356787 DOI: 10.1016/J.Jcf.2005.11.001 |
0.467 |
|
| 2006 |
Muhlebach M, Button B, Leigh M, Boucher R. 205 Serum biomarkers in CF lung disease Journal of Cystic Fibrosis. 5: S48. DOI: 10.1016/S1569-1993(06)80187-6 |
0.405 |
|
| 2005 |
Muhlebach MS, Alexis N, Noah TL. 75 EFFECT OF PSEUDOMONAS AERUGINOSA ON ALVEOLAR MACROPHAGES IN CYSTIC FIBROSIS Journal of Investigative Medicine. 53: S399.6-S400. DOI: 10.2310/6650.2005.00205.74 |
0.342 |
|
| 2004 |
Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatric Pulmonology. 37: 393-9. PMID 15095321 DOI: 10.1002/Ppul.20010 |
0.436 |
|
| 2004 |
Becker MN, Sauer MS, Muhlebach MS, Hirsh AJ, Wu Q, Verghese MW, Randell SH. Cytokine secretion by cystic fibrosis airway epithelial cells. American Journal of Respiratory and Critical Care Medicine. 169: 645-53. PMID 14670800 DOI: 10.1164/Rccm.200207-765Oc |
0.394 |
|
| 2002 |
Muhlebach MS, Noah TL. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 165: 911-5. PMID 11934713 DOI: 10.1164/Ajrccm.165.7.2107114 |
0.502 |
|
| 1999 |
Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. American Journal of Respiratory and Critical Care Medicine. 160: 186-91. PMID 10390398 DOI: 10.1164/Ajrccm.160.1.9808096 |
0.512 |
|
| Show low-probability matches. |
